"Interferon beta-1b" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
- Interferon beta-1b
- beta-1b, Interferon
- Interferon Beta, Ser(17)
- Ser(17) IFN-beta
- Serine(17) Interferon Beta
- Interferon beta 1b
- 1b, Interferon beta
- beta 1b, Interferon
- IFN-Beta Ser
- Interferon Beta, Serine(17)
Below are MeSH descriptors whose meaning is more general than "Interferon beta-1b".
Below are MeSH descriptors whose meaning is more specific than "Interferon beta-1b".
This graph shows the total number of publications written about "Interferon beta-1b" by people in this website by year, and whether "Interferon beta-1b" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Interferon beta-1b" by people in Profiles.
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. Mult Scler. 2019 05; 25(6):837-847.
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Mult Scler. 2019 04; 25(4):565-573.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. JAMA Neurol. 2015 Dec; 72(12):1458-65.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. J Neurol. 2015 Nov; 262(11):2466-71.
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study. Eur Neurol. 2014; 71(3-4):173-9.
The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Mult Scler. 2013 Nov; 19(13):1765-72.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
Evidence-based medicine: promise and pitfalls. Mult Scler. 2012 Jul; 18(7):947-8.
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics J. 2013 Oct; 13(5):443-51.
Variability in detection and quantification of interferon ?-1b-induced neutralizing antibodies. J Neuroinflammation. 2012 Jun 15; 9:129.